Dr. Kiseljak-Vassiliades is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
12605 E 16th Ave
Aurora, CO 80045Phone+1 720-848-0000Fax+1 720-848-2651
Education & Training
University of ColoradoFellowship, Endocrinology, Diabetes, and Metabolism, 2009 - 2012
Johns Hopkins UniversityResidency, Internal Medicine, 2005 - 2009
Arizona College of Osteopathic Medicine of Midwestern UniversityClass of 2005
Certifications & Licensure
CO State License 2009 - 2025
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Publications & Presentations
PubMed
- Dlk1 is a novel adrenocortical stem/progenitor cell marker that predicts malignancy in adrenocortical carcinoma.Katia Mariniello, James F H Pittaway, Barbara Altieri, Kleiton Silva Borges, Irene Hadjidemetriou
Cancer Communications. 2025-03-04 - Pathological findings of immunotherapy-induced nephrotoxicity in a humanized immune system mouse model.Sarah Asby, Lauren E Thompson, Michael Goedken, Scott M Lucia, Adrian T Dominguez
Kidney International. 2025-02-06 - Novel repurposing of sulfasalazine for the treatment of adrenocortical carcinomas, probably through the SLC7A11/xCT-hsa-miR-92a-3p-OIP5-AS1 network pathway.Chitra Subramanian, Kelli McNamara, Seth W Croslow, Yanqi Tan, Daniel Hess
Surgery. 2025-01-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
